These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38935607)

  • 1. Major Gaps in the Cascade of Care for Opioid Use Disorder: Implications for Clinical Practice.
    Arwady MA; Delphin-Rittmon M; Volkow ND
    JAMA; 2024 Sep; 332(9):701-702. PubMed ID: 38935607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family Physicians Play Key Role in Bridging the Gap in Access to Opioid Use Disorder Treatment.
    Abraham R; Wilkinson E; Jabbarpour Y; Bazemore A
    Am Fam Physician; 2020 Jul; 102(1):10. PubMed ID: 32603069
    [No Abstract]   [Full Text] [Related]  

  • 3. Buprenorphine prescribing for opioid use disorder in medical practices: can office-based out-patient care address the opiate crisis in the United States?
    Rhee TG; Rosenheck RA
    Addiction; 2019 Nov; 114(11):1992-1999. PubMed ID: 31307111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the US.
    Stein BD; Saloner B; Schuler MS; Gurvey J; Sorbero M; Gordon AJ
    JAMA; 2021 Jun; 325(21):2206-2208. PubMed ID: 34061152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Buprenorphine Prescribing in Community Health Centers.
    Hartung DM; Voss RW; Bailey SR; Huguet N; Muench J
    JAMA Health Forum; 2024 Apr; 5(4):e240634. PubMed ID: 38669032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of medications used for opioid use disorder in emergency departments: A cross-sectional analysis of the 2020 National Hospital Ambulatory Medical Care Survey.
    Lee S; Sun L; Vakkalanka JP
    Am J Emerg Med; 2024 Aug; 82():52-56. PubMed ID: 38795424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Waivered Clinicians Prescribing Buprenorphine and Prescription Volume by Patient Limit.
    Luo Q; Erikson CE
    JAMA; 2023 May; 329(20):1792-1794. PubMed ID: 37103912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Datapoints: regional variation in benzodiazepine prescribing for patients on opioid agonist therapy.
    Park TW; Bohnert AS; Austin KL; Saitz R; Pizer SD
    Psychiatr Serv; 2014 Jan; 65(1):4. PubMed ID: 24382761
    [No Abstract]   [Full Text] [Related]  

  • 9. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
    Jones CM; McCance-Katz EF
    Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007-2017.
    McBain RK; Dick A; Sorbero M; Stein BD
    Ann Intern Med; 2020 Apr; 172(7):504-506. PubMed ID: 31905379
    [No Abstract]   [Full Text] [Related]  

  • 11. US ED Opioid-Related Visits Increase, While Use of Medication for Opioid Use Disorder Undetectable, 2011-2016.
    Shastry S; Manini AF; Richardson LD; Lin MP
    J Gen Intern Med; 2020 Mar; 35(3):965-966. PubMed ID: 31414352
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment Approaches for Opioid Use Disorder Offered in US Substance Use Treatment Facilities.
    Park TW; Shuey B; Liebschutz J; Cantor J; Anderson TS
    JAMA; 2024 Aug; 332(6):502-504. PubMed ID: 38990551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mixed-method comparison of physician-reported beliefs about and barriers to treatment with medications for opioid use disorder.
    Haffajee RL; Andraka-Christou B; Attermann J; Cupito A; Buche J; Beck AJ
    Subst Abuse Treat Prev Policy; 2020 Sep; 15(1):69. PubMed ID: 32928272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Buprenorphine prescribing by APRNs.
    Rundio A
    J Addict Nurs; 2012 Feb; 23(1):80-1. PubMed ID: 22468666
    [No Abstract]   [Full Text] [Related]  

  • 15. Using buprenorphine to treat patients with opioid use disorder.
    Radi JK; Fogarty KJ; Lagerwey MD
    JAAPA; 2019 Oct; 32(10):30-35. PubMed ID: 31513035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rethinking Opioid Dose Tapering, Prescription Opioid Dependence, and Indications for Buprenorphine.
    Chou R; Ballantyne J; Lembke A
    Ann Intern Med; 2019 Sep; 171(6):427-429. PubMed ID: 31450240
    [No Abstract]   [Full Text] [Related]  

  • 17. Buprenorphine Prescribing and Challenges Faced Among National Health Service Corps Clinicians.
    Rowan K; Shah SV; Binns S; Murphy E; Satorius J; Ghobadi A; Krauss D; Robbins C; Schoebel V; Knudson A; Kepley H;
    JAMA Netw Open; 2024 May; 7(5):e2411742. PubMed ID: 38758556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-Career and Graduating Physicians More Likely to Prescribe Buprenorphine.
    Peterson LE; Morgan ZJ; Eden AR
    J Am Board Fam Med; 2020; 33(1):7-8. PubMed ID: 31907240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine Prescribing Not Contingent on Counseling, Other Services.
    Harris E
    JAMA; 2023 Jun; 329(22):1908. PubMed ID: 37223956
    [No Abstract]   [Full Text] [Related]  

  • 20. Growing importance of high-volume buprenorphine prescribers in OUD treatment: 2009-2018.
    Schuler MS; Dick AW; Gordon AJ; Saloner B; Kerber R; Stein BD
    Drug Alcohol Depend; 2024 Jun; 259():111290. PubMed ID: 38678682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.